What is hysingla er?

Hysingla ER is the brand name for hydrocodone bitartrate in an extended‑release (ER) form. It’s an opioid pain medication used for the long‑term, around‑the‑clock treatment of moderate to severe pain in adults (and sometimes others) when such pain requires continuous daily dosing.

Key points:
- ER (extended‑release) means the medicine is released slowly over time to provide steady pain relief, usually taken as directed by a clinician.
- It is a Schedule II controlled substance due to the risk of addiction, abuse, and overdose.
- It should be used exactly as prescribed. It is not for as-needed (PRN) use, and you should not alter the dose or frequency without your doctor’s guidance.
- Common side effects: constipation, nausea, vomiting, dizziness, drowsiness, headache, or dry mouth. Serious risks include slowed or difficult breathing, severe drowsiness, confusion, low blood pressure, and potential overdose.
- Important safety: avoid alcohol and other central nervous system depressants while taking Hysingla ER; there are significant drug interactions, especially with certain antidepressants, antifungals, and other opioids.
- Not for use in people who are not opioid-tolerant unless specifically prescribed; opioid use in pregnancy can lead to neonatal opioid withdrawal syndrome.

If you’re asking because you or someone you know is taking Hysingla ER or considering it, I can help with more specifics (how it’s typically used, common side effects, interactions, or safety tips). Let me know what you’d like to know or whether you want guidance on questions to ask a healthcare provider.